Published in Z Rheumatol on February 01, 2006
[Clinical pathways in rheumatological inpatient treatment - a structured process management]. Z Rheumatol (2007) 3.55
[Amendment of the structural quality for inpatient rheumatology. A forward-looking concept]. Z Rheumatol (2011) 1.74
[The G-DRG system 2008. Relevant changes for rheumatology]. Z Rheumatol (2008) 1.64
[What changes for rheumatologists in the G-DRG system 2006?]. Z Rheumatol (2006) 1.33
[Treat-to-target (T2T) from the perspective of inpatient rheumatology]. Z Rheumatol (2011) 1.01
[The elder patient with a rheumatic disease and comorbidities. Aspects of rheumatology in an ageing population]. Z Rheumatol (2006) 0.81
[The speciality of rheumatology is on the right path in the G-DRG treatment reimbursement system]. Z Rheumatol (2006) 0.78
[§ 116b SGB V (social insurance code, book five) for rheumatology patients. An empirical assessment on the basis of administrative data]. Z Rheumatol (2011) 0.77
[Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016]. Z Rheumatol (2017) 0.75
[Changes for the field of rheumatology in the G-DRG-System 2007]. Z Rheumatol (2007) 0.75
[How to finance and increase the appeal of rheumatology training : view of the Association of Rheumatology Clinics in Germany (VRA) on challenges and successful strategies]. Z Rheumatol (2011) 0.75
[Clinical pathways: effective and efficient inpatient treatment]. Chirurg (2003) 2.71
[Rheumatologic treatment in the G-DRG system]. Z Rheumatol (2004) 2.58
[Structural quality of acute internal medicine rheumatology clinics--Project Group of the Association of Rheumatologic Acute Clinics]. Z Rheumatol (2002) 2.54
[The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives]. Z Rheumatol (2005) 2.31
Maintenance of exercise in women with fibromyalgia. Arthritis Rheum (2005) 1.18
[Clinical pathways in rheumatological inpatient treatment - a structured process management]. Z Rheumatol (2007) 3.55
[Rheumatologic treatment in the G-DRG system]. Z Rheumatol (2004) 2.58
[The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives]. Z Rheumatol (2005) 2.31
A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol (1997) 1.78
[The G-DRG system 2008. Relevant changes for rheumatology]. Z Rheumatol (2008) 1.64
[International classification of functioning, disability and health and its significance for rheumatology]. Z Rheumatol (2007) 1.53
[Changes for rheumatology in the G-DRG system 2005]. Z Rheumatol (2005) 1.45
[Difficult course of rhabdomyolysis in influenza A/H1N1]. Dtsch Med Wochenschr (2013) 1.45
Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol (1996) 1.44
A case of endocarditis with vasculitis due to Actinobacillus actinomycetemcomitans: a 16S rDNA signature for distinction from related organisms. Clin Infect Dis (1998) 1.42
No primary association between LMP2 polymorphisms and extraspinal manifestations in spondyloarthropathies. Ann Rheum Dis (1997) 1.41
[Rheumatology coding guideline. A guideline for clinical practice]. Z Rheumatol (2002) 1.40
[Value of inpatient care in rheumatoid arthritis-an evidence based report]. Z Rheumatol (2004) 1.39
[Classification of severely injured patients in the G-DRG System 2008]. Unfallchirurg (2009) 1.38
[What changes for rheumatologists in the G-DRG system 2006?]. Z Rheumatol (2006) 1.33
A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) (2002) 1.27
[G-DRG system 2009: relevant changes for rheumatology]. Z Rheumatol (2009) 1.22
Alanine is helix-stabilizing in both template-nucleated and standard peptide helices. Proc Natl Acad Sci U S A (1999) 1.20
[Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area]. Z Rheumatol (2006) 1.18
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol (1996) 1.16
[Hospital financing for 2011: relevant changes in rheumatology]. Z Rheumatol (2011) 1.15
[Adjustment of the German DRG system in 2009]. Urologe A (2009) 1.15
Identification of a unique Helicobacter species by 16S rRNA gene analysis in an abdominal abscess from a patient with X-linked hypogammaglobulinemia. J Clin Microbiol (2000) 1.15
Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol (1999) 1.13
Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum (1998) 1.12
Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum (1998) 1.12
[Appropriate representation of rheumatology in the G-DRG system]. Z Rheumatol (2004) 1.05
Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol (1996) 1.01
[Possibilities and limitations for the representation of ENT medicine in the G-DRG reimbursement system. Results of the DRG evaluation project]. HNO (2006) 1.01
Emergency coronary artery bypass grafting after failed coronary angioplasty: what has changed in a decade? Ann Thorac Surg (2000) 1.00
[Hospital financing in 2012 - Relevant changes for rheumatology]. Z Rheumatol (2012) 1.00
[The G-DRG System 2009--relevant changes for rheumatology]. Z Rheumatol (2010) 0.99
[Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO]. Z Rheumatol (2003) 0.96
Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis. Ann Rheum Dis (2002) 0.96
Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion (2004) 0.92
Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining. Rheumatol Int (1982) 0.90
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies. J Autoimmun (2001) 0.90
Irregular cytokine pattern of CD4+ T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis. Scand J Immunol (1999) 0.90
[Structures of acute rheumatic care]. Z Rheumatol (2006) 0.89
Immune responses towards intestinal bacteria--current concepts and future perspectives. Z Gastroenterol (1997) 0.87
Identification of health problems in patients with acute inflammatory arthritis, using the International Classification of Functioning, Disability and Health (ICF). Clin Exp Rheumatol (2006) 0.87
[Hospital financing in 2013: relevant changes for rheumatology]. Z Rheumatol (2013) 0.86
[Stroke treatment in the 2006 German diagnosis-related group system]. Nervenarzt (2006) 0.86
Introduction of diagnosis-related groups in Germany: evaluation of impact on in-patient care in a dermatological setting. Eur J Public Health (2007) 0.86
Heart surgery in patients aged eighty years and above: determinants of morbidity and mortality. Thorac Cardiovasc Surg (1997) 0.85
Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites. Ann Nutr Metab (1986) 0.84
[Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association]. Med Klin (Munich) (1996) 0.84
HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis. Scand J Immunol (1996) 0.84
[Hospital financing in 2014. Relevant changes for rheumatology]. Z Rheumatol (2014) 0.84
Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology (2000) 0.83
Expression of host defense scavenger receptors in spondylarthropathy. Arthritis Rheum (2001) 0.83
Ankylosing spondylitis in monozygotic twins: studies on immunological parameters. Ann Rheum Dis (1999) 0.83
[Early rehabilitation care in the hospital--definition and indication. Results of the expert group "Early Rehabilitation Care in the Hospital"]. Rehabilitation (Stuttg) (2005) 0.82
HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides. Clin Exp Immunol (2003) 0.82
Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens (2002) 0.82
[Financing of inpatient orthopedics and trauma surgery in the G-DRG system 2010]. Unfallchirurg (2010) 0.81
International Classification of Functioning, Disability and Health (ICF) Core Set for patients with acute arthritis. Clin Exp Rheumatol (2007) 0.81
In vitro testing of bioprostheses: influence of mechanical stresses and lipids on calcification. Ann Thorac Surg (1998) 0.81
CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins. Clin Exp Immunol (2001) 0.81
Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis. Clin Exp Immunol (1999) 0.81
TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis. Hum Immunol (1996) 0.81
Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients? Nephrol Dial Transplant (2000) 0.81
T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation. Transplantation (1998) 0.80
IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum (2001) 0.80
[Complexity level simulation in the German diagnosis-related groups system: the financial effect of coding of comorbidity diagnostics in urology]. Urologe A (2012) 0.80
Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells. Ann N Y Acad Sci (1998) 0.80
[Orthopedic and trauma surgery in the German DRG System 2007]. Unfallchirurg (2007) 0.79
[Proinflammatory cytokines and cardiac pump function]. Z Kardiol (1997) 0.79
[ENT medicine and head and neck surgery in the G-DRG system 2008]. HNO (2008) 0.79
Outcome of women is impaired in patients undergoing emergency coronary artery bypass grafting for failed PTCA. Z Kardiol (2001) 0.79
[Interdisciplinary rheumatology in internal medicine]. Z Rheumatol (2005) 0.79
[Hospital financing in 2015. Relevant changes for rheumatology]. Z Rheumatol (2015) 0.79
Psoriatic arthritis: clinical aspects, genetics, and the role of T cells. Curr Opin Rheumatol (2001) 0.78
[Management of nonspecific low back pain. The new national guidelines 2011]. Z Rheumatol (2012) 0.77
[Secondary vasculitides and vasculitis mimics]. Z Rheumatol (2012) 0.77